Complications of Ethanol-amine Oleate Intralesional Sclerotherapy
NCT ID: NCT04930952
Last Updated: 2021-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2019-02-28
2021-03-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Study Between Sclerosing Agents Used in Treatment of Vascular Malformation
NCT07320430
Treatment of Venous Malformation
NCT05586919
Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
NCT04104464
Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study
NCT05494710
N-butyl-2-cyanoacrylate, Iso-amyl-2-cyanoacrylate and Hypertonic Glucose With 72% Chromated Glycerin in Gastric Varices
NCT02330731
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ethanol-amine Oleate Sclerotherapy Injection
Intralesional Sclerotherapy Injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Patients with Klippel-Trenaunay syndrome
3. Patients mental or physical disabilities
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Suez Canal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Arafat
Assistant Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Arafat, MSc
Role: PRINCIPAL_INVESTIGATOR
Assistant Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suez Canal University
Ismailia, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
157-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.